featured
Prognostic Value of the 21-Gene Breast Recurrence Score Assay for HR+/HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial)
Breast Cancer Res Treat 2024 Jun 26;[EPub Ahead of Print], T Iwamoto, N Niikura, K Watanabe, T Takeshita, Y Kikawa, K Kobayashi, N Iwakuma, T Okamura, T Kobayashi, Y Katagiri, M Kitada, N Tomioka, Y Miyoshi, H Shigematsu, M Miyashita, H Ishiguro, N Masuda, S SajiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.